4. •Cytotron generates RFQMR from 864 Guns.
•RFQMR is a high power multi-frequency, electromagnetic
beam.
•RFQMR alters TMP to start Cell Division (Mitosis).
•Stimulation of chondrocytes mitosis leads to cartilage
regeneration.
•It is a new device for In-Vivo and In-Vitro Tissue Regeneration
/Degeneration and Repair Engineering.
•The work on this Technology started in 1987 and is based on
and is somewhat similar to Nuclear Magnetic Resonance.
TISSUE ENGINEERING: WB-RFQMR
5. TISSUE REGENERATION FOR TREATMENT OF
OSTEOARTHRITIS
The first Whole Body Rotational Field Quantum Nuclear
Magnetic Resonance (WB-RFQMR), designed to expose the
whole Human Body to Polymodulated Resonating Radio
Frequency Signals for therapeutic purposes.
Throughout life cells die and are replaced. In our youth, this
balance is maintained. With age and other problems, cells
replaced are less than cells dying.
In cartilage this leads to decreased cartilage mass. If we
cause chondrocytes to regenerate, then osteoarthritis can be
reversed.
Altering TMP with the help of Radio Medicine can alter cell
mitosis.
6. Near-Radio and Radio frequencies. This part of the EM
spectrum used for the first time in Medical Field.
Currently used in Oceanography and Submarines
RFQMR ON THE EM SPECTRUM
7. Many cellular activities are closely linked with the trans-
membrane potential (TMP).
TMP plays an important role in the synthesis of many
proteins
Selective alteration of TMP can initiate synthesis of HSP
group of proteins initiating mitosis or production of p53
group of proteins arresting active mitosis.
BASIS OF RFQMR THERAPY
8. CHONDROGENESIS
No change in equilibrium between hydrogen proton and negative charge carriers in the extra cellular
cartilage matrix – No Stream Potential.
A Streaming potential is created in the ECM during load bearing caused by the efflux of fixed
negative charged fluid forced out of cartridge tissue with active influx of hydrogen proton.
9. Generation of streaming voltage potentials flow in the joint is
caused by forced movement of hydrogen Protons in the ECM
due to alteration in RFQMR spin in the Hydrogen
atoms, causing stimulation of Chondrocytes in the ECM.
MECHANISM OF THE EFFECT OF
RFQMR SPIN ON THE CONDROCYTES
10. Ability to communicate with the cells and take over the cell’s
command and control and effect successful regeneration.
Inducing communication between the genes and the
protoplasmic glycoproteinic complexes (PGC) to promote cell
mitosis.
HYPOTHESIZED MECHANISM OF ACTION
RFQMR IN THE TREATMENT OF
OSTEOARTHRITIS
11. The most common form of
arthritis is Osteoarthritis.
One out of eight adults are
affected by this.
The Cartilage wears out.
Bone rubs against bone.
Joints are less able to absorb
shock.
OSTEOARTHRITIS
12. Age
Overweight
General wear and tear of joints.
Estrogen deficiency – Post-menopause women.
Joint injury – Single / Repeated
Repeated joint stress - squatting, kneeling, or
heavy lifting.
Joint diseases - rheumatoid arthritis, Gout
Genetic predisposition.
CONTRIBUTORY FACTORS:
OSTEOARTHRITIS
13. Grating sound
Pain
Stiffness
Deformity
Loss of mobility
EFFECTS OF OSTEOARTHRITIS
16. • Patient selection.
• Pre treatment tests.
• Patient lies on Cytotron bed.
• Bed goes inside gantry.
• RFQMR Beam is focused on the treatment area using
LASER guides
• Dose: Calculated & applied by CYTOTRON.
• Duration of treatment: 30 to 60 minutes daily for 21 days
METHOD OF TREATMENT:
CYTOTRON
17. Considerations
Proton density of tissue
Tissue / Air reflection
Tissue / Air refraction
Permeability
Penetration
Conductivity
Hence focus is by:
Target
Fixed proton density
RFQMR DOSIMETRY
19. The Patient experiences
no pain or discomfort.
Some patients experience:
Mild tingling sensation
Pin-prick feeling
DURING THERAPY
20. Subjective Improvement:
o Pain Relief
o Walk more comfortably
o Decreased deformity
o Squat down on the floor
o Climb stairs
Ref:IJASM 2004; 48(2): 1 – 7,(Journal of India's Armed Forces)
Sainik Samachar Vol. 51 - No.16, 16-31
HOW PATIENT KNOWS HE IS BETTER
27. *Results are for n=202 or 404 knees. Results are under publication.
Values are for Mean +SEM, * represents r < 0.001 between pre-treatment
and immediate post treatment, t represents r < 0.001 between pre-treatment
and 90 days post-treatment.
RESULT OF PHASE II CONCLUDED*
28. Success - 85% very good, -10 to 15 % fair
Failure - 5 to 10 %
Harm to patient – Zero %
Duration of effectiveness: 4 years +
RESULTS
29. 80% chances that the patient is saved
from surgery.
Surgery is possible if Cytotron is not
effective, but Cytotron therapy is not an
alternative after failure of Surgery.
CONCLUSION